Kalbe Morinaga Indonesia is primarily engaged in dry, condensed, evaporated products activity. Its headquarters is located in Jawa Barat. The company was founded in 2005. Kalbe Morinaga Indonesia is a joint venture between PT Kalbe Farma Tbk, a leading pharmaceutical company in Indonesia, and Morinaga Milk Industry Co., Ltd., a renowned Japanese dairy company. The collaboration combines Kalbe's extensive distribution network and local market expertise with Morinaga's advanced dairy technology and product innovation. The company focuses on producing high-quality nutritional products, including infant formula and other dairy-based nutritional supplements. Some of its well-known product brands include Chil Kid, Chil School, and Chil Mil, which cater to different stages of child development. Kalbe Morinaga Indonesia operates several production facilities in Indonesia, ensuring a robust local presence and the ability to meet domestic demand efficiently. The company also exports its products to various countries in Southeast Asia, contributing to its growing international footprint. As part of its commitment to quality and safety, Kalbe Morinaga Indonesia adheres to stringent manufacturing standards and is a member of several industry associations that promote best practices in the food and nutrition sector. The company aims to enhance the health and well-being of its consumers by providing innovative and nutritious products. Its mission is to be a trusted partner in nurturing the next generation, aligning with its vision of becoming a leading player in the global nutrition industry.
Headquarters
Kawasan Industri Indotaisei, Sektor I A Blok Q1, Kota Bukit Indah
Karawang; West Java;
Postal Code: 41373
Contact Details: Purchase the PT Kalbe Morinaga Indonesia report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service